feed,title,long_url,short_url
Benzinga,Aldeyra Highlights 12-Month Safety Data Of Reproxalap In Dry Eye Disease Patients,https://benzinga.com/general/biotech/23/02/31096373/aldeyra-highlights-12-month-safety-data-of-reproxalap-in-dry-eye-disease-patients,https://da.gd/MTsxj1
